Volatile organic compounds of exhaled breath in lung cancer and lung inflammatory diseases

I. Taivans, G. Strazda, N. Jurka, U. Kopeika, A. Pirtnieks, L. Balode, M. Bukovskis, A. Kislina, J. Aprinceva, L. Logina (Riga, Latvia)

Source: Annual Congress 2013 –Epidemiology, screening and diagnosis of lung cancer
Session: Epidemiology, screening and diagnosis of lung cancer
Session type: Oral Presentation
Number: 1823
Disease area: Airway diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Taivans, G. Strazda, N. Jurka, U. Kopeika, A. Pirtnieks, L. Balode, M. Bukovskis, A. Kislina, J. Aprinceva, L. Logina (Riga, Latvia). Volatile organic compounds of exhaled breath in lung cancer and lung inflammatory diseases. Eur Respir J 2013; 42: Suppl. 57, 1823

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Differences in volatile organic compounds (VOC) determined in exhaled breath in two populations of lung cancer (LC): With and without COPD
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013


Volatile organic compounds in exhaled breath samples as potential biomarkers in early diagnosis of lung cancer – (Ege translational pulmonology research group [EgeTPAG])
Source: International Congress 2016 – Prognostic variables in lung cancer II
Year: 2016

The research on early detection of lung cancer with exhaled volatile organic compounds
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014

Analysis of exhaled breath with electronic nose and diagnosis of lung cancer by support vector machine
Source: Annual Congress 2013 –Epidemiology, screening and diagnosis of lung cancer
Year: 2013


Using exhaled breath profiles in the discrimination between COPD, lung cancer and their co-morbidity
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015

Exhaled breath temperature in NSCLC: Could be a new non invasive marker?
Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours
Year: 2014



Early detection of lung cancer in exhaled breath condensate using miRNA markers
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015


Volatile organic compounds in exhaled breath of patients with COPD ± lung cancer and their correlation with FEV1-values
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014

Detection of early stage lung cancer by electronic nose
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013


Analysis of exhaled breath with electronic nose and discrimination of lung cancer and COPD by logistic regression analysis
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013


Aspergillus spp. colonization in exhaled breath condensate of lung cancer patients from Puglia Region of Italy
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014


Analysis of exhaled breath with electronic nose and diagnosis of lung cancer by multifactorial logistic regression analysis
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013


Detection of lung cancer using expired breath analysis by ion mobility spectrometry
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015

Breath collection related factors may influence electronic nose ability to detect lung cancer
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015


Exhaled volatile organic compounds as biomarkers for respiratory diseases
Source: Eur Respir Monogr 2010; 49: 130-139
Year: 2010


LATE-BREAKING ABSTRACT: New algorithm of lung cancer diagnosis by analysis of exhaled breath with electronic nose and multifactorial logistic regression method
Source: International Congress 2014 – Thoracic tumours: news from the lab
Year: 2014


Proteomics and screening of lung cancer: Biomarkers selection by mass spectrometry and ELISA in the exhaled breath condensate (EBC)
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013


Early diagnosis of lung cancer by the electronic nose: Preliminary results
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014


Exhaled biomarkers in lung cancer
Source: Eur Respir J 2009; 34: 261-275
Year: 2009



Smoking status affects VRI assissted prediction of postoperative FEV1 and DL,CO in patients with lung cancer
Source: International Congress 2014 – Outcome prediction and imaging in thoracic surgery
Year: 2014